Skip to content

Wavefront-guided LASIK for Correction of Myopia

Wavefront-guided LASIK for Correction of Myopia

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01682434
Enrollment
0
Registered
2012-09-11
Start date
2011-05-31
Completion date
Unknown
Last updated
2014-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Brief summary

Laser in situ keratomileusis is a successful procedure for the treatment of low to moderate myopia. Advances over the last decade have allowed LASIK to also correct higher order wavefront aberrations. In low myopia, there seem to be a minor effect of such wavefront-guided treatment. However, it remains to be established whether there is a beneficial effect in higher degrees of myopia. The study aims to determine whether myopic subjects (-6 to -10 diopters) with higher-than-average preoperative higher-order aberrations have benefit of wavefront-guided treatment. Subjects are randomized to wavefront-guided treatment in one eye, and conventional treatment in the other.

Interventions

Wavefront guided treatment in one eye, conventional in the other.

Sponsors

Aarhus University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
20 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Age 20 to 50 years * No known ocular or systemic disease * Not pregnant or breastfeeding * Myopia between -6.0 and -10.0 diopters * Astigmatism below 2.0 diopters * Difference of less than 1.0 diopters in spherical equivalent between eyes * Normal corneal topography * Corneal thickness sufficient for planned treatment

Exclusion criteria

* Patients that do not fulfill inclusion criteria * Insufficient quality of ocular wavefront measurement

Design outcomes

Primary

MeasureTime frame
Visual acuity12 months

Secondary

MeasureTime frameDescription
Ocular higher order aberrations12 monthsHartmann-Schack wavefront aberrometry using the Zeiss Meditec WASCA

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026